CREDIT AGREEMENT by and among WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent, THE LENDERS THAT ARE PARTIES HERETO as the Lenders, NEOGENOMICS, INC., as Parent, NEOGENOMICS LABORATORIES, INC., PATH LABS, LLC, and the other parties...Credit Agreement • December 31st, 2015 • Neogenomics Inc • Services-testing laboratories • New York
THIS CREDIT AGREEMENT (this “Agreement”), is entered into as of December 30, 2015, by and among the lenders identified on the signature pages hereof (each of such lenders, together with its successors and permitted assigns, is referred to hereinafter as a “Lender”, as that term is hereinafter further defined), WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as administrative agent for each member of the Lender Group and the Bank Product Providers (in such capacity, together with its successors and assigns in such capacity, “Agent”), NEOGENOMICS, INC., a Nevada corporation (“Parent”), NEOGENOMICS LABORATORIES, INC., a Florida corporation (“NeoGenomics”), PATH LABS, LLC, a Delaware limited liability company (“PathLogic”), and the other parties signatory hereto as “Borrowers” from time to time (such other parties, together with NeoGenomics and PathLogic, are referred to hereinafter each individually as a “Borrower”, and individually and collectively, jointly and se
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 31st, 2015 • Neogenomics Inc • Services-testing laboratories • New York
This Registration Rights Agreement (this “Agreement”) is made as of this 30th day of December, 2015, by and between NeoGenomics, Inc., a Nevada corporation (the “Company”), and GE Medical Systems Information Technologies, Inc., a Wisconsin corporation (the “Investor”).
INVESTOR BOARD RIGHTS, LOCKUP, AND STANDSTILL AGREEMENTInvestor Rights Agreement • December 31st, 2015 • Neogenomics Inc • Services-testing laboratories • New York
This Investor Board Rights, Lockup, and Standstill Agreement (this “Agreement” or “Investor Rights Agreement”) is made as of this 30th day of December, 2015, by and between NeoGenomics, Inc., a Nevada corporation (the “Company”), on the one hand, and GE Medical Systems Information Technologies, Inc., a Wisconsin corporation (the “Investor”), and General Electric Company, a New York corporation (“GE”) acting for itself and each GE Subsidiary (as defined below), on the other hand.
TERM LOAN AND GUARANTY AGREEMENT,Term Loan and Guaranty Agreement • December 31st, 2015 • Neogenomics Inc • Services-testing laboratories • New York
This TERM LOAN AND GUARANTY AGREEMENT, dated as of December 30, 2015, is entered into by and among NEOGENOMICS LABORATORIES, INC., a Florida corporation (the “Borrower”), NEOGENOMICS, INC., a Nevada corporation (“Holdings”), CERTAIN SUBSIDIARIES OF HOLDINGS, as Guarantors, the Lenders party hereto from time to time, and AB PRIVATE CREDIT INVESTORS LLC (“AB-PCI”), as Administrative Agent (together with its permitted successors and assigns in such capacity, the “Administrative Agent”) and as Collateral Agent (together with its permitted successors and assigns in such capacity, the “Collateral Agent”).
AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENTStock Purchase Agreement • December 31st, 2015 • Neogenomics Inc • Services-testing laboratories
THIS AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT (this “Amendment”) is made as of December 28, 2015, by and among GE Medical Holding AB, a private limited company (privat aktiebolag) organized under the laws of the Kingdom of Sweden (Reg. No. 556648-9315) (“Seller”), NeoGenomics Laboratories, Inc., a Florida corporation (“Buyer”), and NeoGenomics, Inc., a Nevada corporation (“Parent”, and together with Seller and Buyer, the “Parties”).
